Brisbane, Australia

Veracity Clinical Research

Basal Cell Nevus Syndrome

Carcinoma

Basal Cell Carcinoma

Psoriasis

Ichthyosis

Syndrome

Lamellar Ichthyosis

Skin Cancer

ASN-002

BMS-986322

Ascend Biopharmaceuticals

Bristol-Myers Squibb (BMS)

Mayne Pharma

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of this study is to evaluate clinical effectiveness and safety of BMS-986322 in participants with moderate-to-severe psoriasis.

A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis

Veracity Clinical Research | Brisbane, Australia

Site insights

Work at this site?

Active trials

A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis

Trial sponsors